Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions.

Grizzi F, Qehajaj D, Yiu D, Bresalier RS, Chiriva-Internati M.

Surg Today. 2020 Jan 31. doi: 10.1007/s00595-020-01965-0. [Epub ahead of print] No abstract available.

PMID:
32002663
2.

A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade.

Mirandola L, Chiriva-Internati M, Bresalier R, Piccotti L, Grizzi F, Marincola FM.

J Transl Med. 2019 Dec 19;17(1):424. doi: 10.1186/s12967-019-02163-4.

3.

Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvement.

Facheris P, Valenti M, Pavia G, Grizzi F, Narcisi A, Costanzo A, Borroni RG.

J Cutan Pathol. 2019 Nov 26. doi: 10.1111/cup.13618. [Epub ahead of print]

PMID:
31769877
4.

On the assessment of angiogenesis: its time to change (go further) from an estimate to a measurement.

Grizzi F, Chiriva-Internati M, Yiu D.

Folia Morphol (Warsz). 2019 Oct 4. doi: 10.5603/FM.a2019.0096. [Epub ahead of print] No abstract available.

5.

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer.

Grizzi F, Castello A, Qehajaj D, Toschi L, Rossi S, Pistillo D, Paleari V, Veronesi G, Novellis P, Monterisi S, Mineri R, Rahal D, Lopci E.

Cancer Immunol Immunother. 2019 Sep;68(9):1537-1545. doi: 10.1007/s00262-019-02387-9. Epub 2019 Sep 3.

PMID:
31482306
6.

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.

Castello A, Toschi L, Rossi S, Finocchiaro G, Grizzi F, Mazziotti E, Qehajaj D, Rahal D, Lopci E.

Clin Lung Cancer. 2020 Jan;21(1):28-36. doi: 10.1016/j.cllc.2019.07.004. Epub 2019 Jul 22.

PMID:
31409523
7.

Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study.

Grizzi F, Fiorino S, Qehajaj D, Fornelli A, Russo C, de Biase D, Masetti M, Mastrangelo L, Zanello M, Lombardi R, Domanico A, Accogli E, Tura A, Mirandola L, Chiriva-Internati M, Bresalier RS, Jovine E, Leandri P, Di Tommaso L.

J Transl Med. 2019 Feb 28;17(1):61. doi: 10.1186/s12967-019-1817-3.

8.

Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression.

Cavalleri T, Bianchi P, Basso G, Celesti G, Grizzi F, Bossi P, Greco L, Pitrone C, Valtorta E, Mauri G, Truini M, Dall'Olio FG, Brandi G, Sartore-Bianchi A, Ricciardiello L, Torri V, Rimassa L, Siena S, Mantovani A, Malesci A, Laghi L; Alleanza contro il Cancro (ACC) Colorectal Cancer Working Group.

Cancer Immunol Res. 2019 May;7(5):751-758. doi: 10.1158/2326-6066.CIR-18-0661. Epub 2019 Feb 25.

PMID:
30804005
9.

Prognostic Impact of Intratumoral Heterogeneity Based on Fractal Geometry Analysis in Operated NSCLC Patients.

Castello A, Russo C, Grizzi F, Qehajaj D, Lopci E.

Mol Imaging Biol. 2019 Oct;21(5):965-972. doi: 10.1007/s11307-018-1299-3.

PMID:
30478506
10.

18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors.

Castello A, Grizzi F, Qehajaj D, Rahal D, Lutman F, Lopci E.

Leuk Lymphoma. 2019 Feb;60(2):367-375. doi: 10.1080/10428194.2018.1488254. Epub 2018 Jul 22.

PMID:
30032683
11.

The Complexity and Fractal Geometry of Nuclear Medicine Images.

Grizzi F, Castello A, Qehajaj D, Russo C, Lopci E.

Mol Imaging Biol. 2019 Jun;21(3):401-409. doi: 10.1007/s11307-018-1236-5.

PMID:
30003453
12.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J.

Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10.

PMID:
29754777
13.

Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review.

Bax C, Taverna G, Eusebio L, Sironi S, Grizzi F, Guazzoni G, Capelli L.

Cancers (Basel). 2018 Apr 18;10(4). pii: E123. doi: 10.3390/cancers10040123. Review.

14.

Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancer.

Castello A, Grizzi F, Toschi L, Rossi S, Rahal D, Marchesi F, Russo C, Finocchiaro G, Lopci E.

Nucl Med Commun. 2018 Jul;39(7):636-644. doi: 10.1097/MNM.0000000000000832.

PMID:
29608508
15.

Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression.

Porta C, Ippolito A, Consonni FM, Carraro L, Celesti G, Correale C, Grizzi F, Pasqualini F, Tartari S, Rinaldi M, Bianchi P, Balzac F, Vetrano S, Turco E, Hirsch E, Laghi L, Sica A.

Cancer Immunol Res. 2018 May;6(5):578-593. doi: 10.1158/2326-6066.CIR-17-0036. Epub 2018 Mar 27.

16.

Is it time to change our vision of tumor metabolism prior to immunotherapy?

Grizzi F, Castello A, Lopci E.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1072-1075. doi: 10.1007/s00259-018-3988-1. Epub 2018 Mar 12. No abstract available.

PMID:
29532102
17.

EUS elastography (strain ratio) and fractal-based quantitative analysis for the diagnosis of solid pancreatic lesions.

Carrara S, Di Leo M, Grizzi F, Correale L, Rahal D, Anderloni A, Auriemma F, Fugazza A, Preatoni P, Maselli R, Hassan C, Finati E, Mangiavillano B, Repici A.

Gastrointest Endosc. 2018 Jun;87(6):1464-1473. doi: 10.1016/j.gie.2017.12.031. Epub 2018 Jan 9.

PMID:
29329992
18.

Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Grizzi F, Basso G, Borroni EM, Cavalleri T, Bianchi P, Stifter S, Chiriva-Internati M, Malesci A, Laghi L.

Inflamm Res. 2018 May;67(5):375-389. doi: 10.1007/s00011-017-1128-1. Epub 2018 Jan 10. Review.

PMID:
29322204
19.

Prostate Cancer: From Genomics to the Whole Body and Beyond.

Grizzi F, Taverna G, Cote RJ, Guazzoni G.

Biomed Res Int. 2017;2017:8707690. doi: 10.1155/2017/8707690. Epub 2017 Nov 9. No abstract available.

20.

Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.

Malesci A, Bianchi P, Celesti G, Basso G, Marchesi F, Grizzi F, Di Caro G, Cavalleri T, Rimassa L, Palmqvist R, Lugli A, Koelzer VH, Roncalli M, Mantovani A, Ogino S, Laghi L.

Oncoimmunology. 2017 Jul 12;6(12):e1342918. doi: 10.1080/2162402X.2017.1342918. eCollection 2017.

21.

Matricellular proteins and survival in patients with pancreatic cancer: A systematic review.

Fiorino S, Bacchi-Reggiani ML, Birtolo C, Acquaviva G, Visani M, Fornelli A, Masetti M, Tura A, Sbrignadello S, Grizzi F, Patrinicola F, Zanello M, Mastrangelo L, Lombardi R, Benini C, Di Tommaso L, Bondi A, Monetti F, Siopis E, Orlandi PE, Imbriani M, Fabbri C, Giovanelli S, Domanico A, Accogli E, Di Saverio S, Grifoni D, Cennamo V, Leandri P, Jovine E, de Biase D.

Pancreatology. 2018 Jan;18(1):122-132. doi: 10.1016/j.pan.2017.11.001. Epub 2017 Nov 4. Review.

PMID:
29137857
22.

Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.

Mirandola L, Pedretti E, Figueroa JA, Chiaramonte R, Colombo M, Chapman C, Grizzi F, Patrinicola F, Kast WM, Nguyen DD, Rahman RL, Daver N, Ruvolo P, Post SM, Bresalier RS, Chiriva-Internati M.

Oncotarget. 2017 Aug 10;8(43):74378-74390. doi: 10.18632/oncotarget.20102. eCollection 2017 Sep 26.

23.

Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.

Rossi S, Toschi L, Castello A, Grizzi F, Mansi L, Lopci E.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2310-2325. doi: 10.1007/s00259-017-3802-5. Epub 2017 Aug 16. Review.

PMID:
28815334
24.

Celiac disease: From pathophysiology to treatment.

Parzanese I, Qehajaj D, Patrinicola F, Aralica M, Chiriva-Internati M, Stifter S, Elli L, Grizzi F.

World J Gastrointest Pathophysiol. 2017 May 15;8(2):27-38. doi: 10.4291/wjgp.v8.i2.27. Review.

25.

Human β-Defensin 2 in Primary Sclerosing Cholangitis.

Chang C, Lleo A, Kananurak A, Grizzi F, Tsuneyama K, Invernizzi P, Bevins CL, Bowlus CL.

Clin Transl Gastroenterol. 2017 Mar 16;8(3):e80. doi: 10.1038/ctg.2017.8.

26.

Comment on "mediator of DNA damage checkpoint protein 1 (MDC1) as a prognostic marker for patients with oral squamous cell carcinoma".

Grizzi F, Yiu D, Stifter S.

J Oral Pathol Med. 2017 Sep;46(8):663-664. doi: 10.1111/jop.12567. Epub 2017 Apr 6. No abstract available.

PMID:
28267241
27.

Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis.

Lopci E, Grizzi F, Russo C, Toschi L, Grassi I, Cicoria G, Lodi F, Mattioli S, Fanti S.

Nucl Med Commun. 2017 Apr;38(4):340-346. doi: 10.1097/MNM.0000000000000656.

PMID:
28263239
28.

Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review.

Capelli L, Taverna G, Bellini A, Eusebio L, Buffi N, Lazzeri M, Guazzoni G, Bozzini G, Seveso M, Mandressi A, Tidu L, Grizzi F, Sardella P, Latorre G, Hurle R, Lughezzani G, Casale P, Meregali S, Sironi S.

Sensors (Basel). 2016 Oct 14;16(10). pii: E1708. Review.

29.

Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.

Lopci E, Toschi L, Grizzi F, Rahal D, Olivari L, Castino GF, Marchetti S, Cortese N, Qehajaj D, Pistillo D, Alloisio M, Roncalli M, Allavena P, Santoro A, Marchesi F, Chiti A.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1954-61. doi: 10.1007/s00259-016-3425-2. Epub 2016 Jun 1.

PMID:
27251642
30.

Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment.

Liguori M, Buracchi C, Pasqualini F, Bergomas F, Pesce S, Sironi M, Grizzi F, Mantovani A, Belgiovine C, Allavena P.

Oncotarget. 2016 Jul 5;7(27):41662-41676. doi: 10.18632/oncotarget.9340.

31.

Cancer heterogeneity and drug metabolism: what we know and what we need to know.

Grizzi F.

Future Oncol. 2016 Jun;12(11):1317-9. doi: 10.2217/fon-2015-0039. Epub 2016 Mar 8. No abstract available.

PMID:
27182685
32.

Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma.

Castino GF, Cortese N, Capretti G, Serio S, Di Caro G, Mineri R, Magrini E, Grizzi F, Cappello P, Novelli F, Spaggiari P, Roncalli M, Ridolfi C, Gavazzi F, Zerbi A, Allavena P, Marchesi F.

Oncoimmunology. 2015 Sep 11;5(4):e1085147. eCollection 2016 Apr.

33.

MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.

Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D.

World J Gastroenterol. 2016 Apr 21;22(15):3907-36. doi: 10.3748/wjg.v22.i15.3907. Review.

34.

Comment on 'Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'.

Grizzi F, Qehajaj D, Chiriva-Internati M, Stifter S.

Br J Cancer. 2016 May 10;114(10):e1. doi: 10.1038/bjc.2015.441. Epub 2016 Apr 14. No abstract available.

35.

Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer.

Galdiero MR, Bianchi P, Grizzi F, Di Caro G, Basso G, Ponzetta A, Bonavita E, Barbagallo M, Tartari S, Polentarutti N, Malesci A, Marone G, Roncalli M, Laghi L, Garlanda C, Mantovani A, Jaillon S.

Int J Cancer. 2016 Jul 15;139(2):446-56. doi: 10.1002/ijc.30076. Epub 2016 Mar 24.

36.

KRAS mutation in lung metastases from colorectal cancer: prognostic implications.

Ghidini M, Personeni N, Bozzarelli S, Baretti M, Basso G, Bianchi P, Tronconi MC, Pressiani T, Grizzi F, Giordano L, Malesci A, Alloisio M, Laghi L, Santoro A, Rimassa L.

Cancer Med. 2016 Feb;5(2):256-64. doi: 10.1002/cam4.592. Epub 2015 Dec 29.

37.

The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.

Erreni M, Siddiqui I, Marelli G, Grizzi F, Bianchi P, Morone D, Marchesi F, Celesti G, Pesce S, Doni A, Rumio C, Roncalli MG, Laghi L, Mantovani A, Allavena P.

J Immunol. 2016 Jan 15;196(2):902-14. doi: 10.4049/jimmunol.1501335. Epub 2015 Dec 16.

38.

Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Fiorino S, Bacchi-Reggiani L, de Biase D, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Acquaviva G, di Tommaso L, Bondi A, Visani M, Sabbatani S, Pontoriero L, Fabbri C, Cuppini A, Pession A, Jovine E.

World J Gastroenterol. 2015 Dec 7;21(45):12896-953. doi: 10.3748/wjg.v21.i45.12896. Review.

39.

Sniffing out prostate cancer: a new clinical opportunity.

Taverna G, Tidu L, Grizzi F.

Cent European J Urol. 2015;68(3):308-10. doi: 10.5173/ceju.2015.593. Epub 2015 Oct 15. Review. No abstract available.

40.

Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial.

Taverna G, Bozzini G, Grizzi F, Seveso M, Mandressi A, Balzarini L, Mrakic F, Bono P, De Franceco O, Buffi N, Lughezzani G, Lazzeri M, Casale P, Guazzoni GF.

World J Urol. 2016 Jun;34(6):797-803. doi: 10.1007/s00345-015-1711-4. Epub 2015 Oct 19.

PMID:
26481226
41.

Pituitary Adenoma and the Chemokine Network: A Systemic View.

Grizzi F, Borroni EM, Vacchini A, Qehajaj D, Liguori M, Stifter S, Chiriva-Internati M, Di Ieva A.

Front Endocrinol (Lausanne). 2015 Sep 11;6:141. doi: 10.3389/fendo.2015.00141. eCollection 2015. Review. No abstract available.

42.

Open partial nephrectomy: ancient art or currently available technique?

Seveso M, Grizzi F, Bozzini G, Mandressi A, Guazzoni G, Taverna G.

Int Urol Nephrol. 2015 Dec;47(12):1923-32. doi: 10.1007/s11255-015-1120-z. Epub 2015 Oct 5. Review.

PMID:
26438327
43.

Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy.

Taverna G, Tidu L, Grizzi F, Stork B, Mandressi A, Seveso M, Bozzini G, Sardella P, Latorre G, Lughezzani G, Buffi N, Casale P, Fiorini G, Lazzeri M, Guazzoni G.

Clin Chem Lab Med. 2016 Mar;54(3):e67-70. doi: 10.1515/cclm-2015-0717. No abstract available.

PMID:
26402886
44.

Re: Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.

Taverna G, Cote R, Grizzi F.

Int J Urol. 2016 Jan;23(1):105. doi: 10.1111/iju.12947. Epub 2015 Sep 9. No abstract available.

45.

Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.

Di Caro G, Cortese N, Castino GF, Grizzi F, Gavazzi F, Ridolfi C, Capretti G, Mineri R, Todoric J, Zerbi A, Allavena P, Mantovani A, Marchesi F.

Gut. 2016 Oct;65(10):1710-20. doi: 10.1136/gutjnl-2015-309193. Epub 2015 Jul 8.

PMID:
26156960
46.

Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer.

Taverna G, Grizzi F, Colombo P, Seveso M, Giusti G, Proietti S, Fiorini G, Lughezzani G, Casale P, Buffi N, Lazzari M, Guazzoni G.

Korean J Urol. 2015 Jun;56(6):435-42. doi: 10.4111/kju.2015.56.6.435. Epub 2015 Jun 2.

47.

Editorial: Prostate Cancer: What We Know and What We Would Like to Know.

Taverna G, Cote RJ, Grizzi F.

Front Oncol. 2015 May 22;5:114. doi: 10.3389/fonc.2015.00114. eCollection 2015. No abstract available.

48.

Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.

Colombo M, Mirandola L, Reidy A, Suvorava N, Konala V, Chiaramonte R, Grizzi F, Rahman RL, Jenkins MR, Nugyen DD, Dalhbeck S, Cobos E, Figueroa JA, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):188-99. doi: 10.3109/08830185.2015.1027629. Review.

49.

Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Review.

PMID:
25901860
50.

Cancer-testis antigens and immunotherapy in the light of cancer complexity.

Grizzi F, Mirandola L, Qehajaj D, Cobos E, Figueroa JA, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):143-53. doi: 10.3109/08830185.2015.1018418. Review.

PMID:
25901859

Supplemental Content

Loading ...
Support Center